ALBO Albireo Pharma Inc

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

$20.04  +0.53 (2.72%)
As of 10/05/2022 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  19,612,509
Average volume:  572,981
Market cap:   $367,734,544
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYMP0T9
Valuation   (See tab for details)
PE ratio:   -11.69
PB ratio:   2.57
PS ratio:   8.09
Return on equity:   -22.09%
Net income %:   -72.02%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy